Table 3.
Clinical factors.
Characteristic | Value |
---|---|
STAGE | |
I | 4 (5.7%) |
II | 5 (7.1%) |
III | 53 (75.7%) |
IV | 8 (11.4%) |
SEX | |
Male | 61 (87.1%) |
Female | 9 (12.9%) |
AGE | |
Range | 35-84 |
Mean ± Std. | 61 ± 10 |
TUMOR LOCATION | |
Left | 33 (47.1%) |
Right | 37 (52.9%) |
KPS | |
≤80 | 41 (58.6%) |
>80 | 29 (41.4%) |
CONCURRENT CHEMOTHERAPY | |
Yes | 38 (54.3%) |
No | 32 (45.7%) |
SMOKING HISTORY | |
Yes | 60 (85.7%) |
No | 10 (14.3%) |
PRESCRIPTION DOSE (Gy) | |
Single fraction | 2.27 ± 0.85 |
Total | 59.10 ± 5.67 |
RP GRADE | |
≥2 | 15 (21.4%) |
<2 | 55 (78.6%) |
KPS, Karnofsky performance status.